5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.81▲ | 2.80▲ | 2.80▲ | 2.75▲ | 2.46▲ |
MA10 | 2.80▲ | 2.81▲ | 2.81▲ | 2.65▲ | 2.33▲ |
MA20 | 2.84▲ | 2.80▲ | 2.78▲ | 2.48▲ | 2.31▲ |
MA50 | 2.76▲ | 2.71▲ | 2.66▲ | 2.27▲ | 1.92▲ |
MA100 | 2.66▲ | 2.57▲ | 2.48▲ | 2.28▲ | N/A |
MA200 | 2.50▲ | 2.38▲ | 2.35▲ | 2.11▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.005▼ | -0.007▼ | 0.037▲ | N/A |
RSI | 57.406▲ | 58.387▲ | 59.809▲ | 64.597▲ | N/A |
STOCH | 56.923 | 36.908 | 42.845 | 75.757 | 53.906 |
WILL %R | -17.241▲ | -29.412 | -29.412 | -12.500▲ | -9.434▲ |
CCI | 86.873 | 46.523 | 66.148 | 91.347 | 200.328▲ |
Saturday, January 23, 2021 02:31 AM
Ellis Investment Partners LLC boosted its holdings in PDS Biotechnology Co. (NASDAQ:PDSB) by 693.3% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange ...
|
Friday, January 15, 2021 12:57 AM
(GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s ...
|
Thursday, January 14, 2021 06:30 AM
FLORHAM PARK, N.J., Jan. 14, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
22/01/21 | 2.76 | 2.85 | 2.69 | 2.83 | 189,400 |
21/01/21 | 2.84 | 2.867 | 2.76 | 2.76 | 140,900 |
20/01/21 | 2.73 | 2.93 | 2.725 | 2.82 | 695,900 |
19/01/21 | 2.70 | 2.74 | 2.63 | 2.70 | 318,600 |
15/01/21 | 2.77 | 2.85 | 2.62 | 2.63 | 335,600 |
14/01/21 | 2.63 | 2.85 | 2.626 | 2.76 | 565,600 |
13/01/21 | 2.49 | 2.60 | 2.44 | 2.60 | 264,300 |
12/01/21 | 2.49 | 2.55 | 2.45 | 2.50 | 266,800 |
11/01/21 | 2.39 | 2.50 | 2.35 | 2.49 | 245,350 |
08/01/21 | 2.53 | 2.62 | 2.35 | 2.39 | 358,800 |
|
|
||||
|
|
||||
|
|